BCL2 and acute lymphoblastic leukemia: In this work we analyzed the cytotoxic effect of BCL2 inhibition by Venetoclax alone or in combination regimen with Nilotinib in primitive and committed CP-CML as well as in Ph+ B-ALL cells.